IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca
IRIS è il sistema di gestione integrata dei dati della ricerca (persone, progetti, pubblicazioni, attività) adottato dall'Università degli Studi di Milano.
AIR nasce in UNIMI nel 2006 con lo scopo di raccogliere, documentare e conservare le informazioni sulla produzione scientifica dell'Università degli Studi di Milano e costituisce di fatto l'Anagrafe della ricerca dell'Ateneo.
EnglishThe prognosis and the quality of life of patients with carcinoid tumors is related either to symptoms from the substances secreted or to progressive tumor growth. Medical treatment with cytotoxic agents is of marginal value for increasing life expectancy and reducing clinical symptoms. Recent studies with interferon have shown interesting results. In the present investigation, 22 patients with carcinoid tumors and syndrome were treated with recombinant interferon alpha-2a (r-IFN alpha-2a) at the dose of 6 x 10(6) IU intramuscularly daily for 8 weeks and three times weekly thereafter. The primary tumor was localized in the foregut (n = 11), midgut (n = 7), hindgut (n = 1), and unknown site (n = 3). Most cases had liver metastasis. Seventeen patients had elevated 5-hydroxyindoloacetic acid (5-HIAA) excretion and 5 had flushing and/or diarrhea as the only clinical manifestation. Six cases presented a complete syndrome (flushing, diarrhea and 5-HIAA excretion). Control of symptoms was obtained in 80% and a 5-HIAA level reduction in 58% of the patients. The interferon treatment was more effective for control of the carcinoid syndrome than for control of tumor growth. The treatment was well tolerated and fever, myalgia, anorexia and fatigue were the most frequent side-effects.
Treatment of carcinoid syndrome with recombinant interferon alpha-2a / M. Di Bartolomeo, E. Bajetta, N. Zilembo, F. de Braud, A. Di Leo, C. Verusio, M. D'Aprile, A. Scanni, M. Barduagni, A. Et, A. Barduagni. - In: ACTA ONCOLOGICA. - ISSN 0284-186X. - 32:2(1993), pp. 235-238. ((Intervento presentato al 3. convegno International workshop on recent advances in diagnosis and treatment in neuroendocrine gut and pancreatic tumors tenutosi a Lofoten nel 1992.
| Titolo: | Treatment of carcinoid syndrome with recombinant interferon alpha-2a | |
| Autori: | ||
| Parole Chiave: | Leukocyte interferon; tumors | |
| Settore Scientifico Disciplinare: | Settore MED/06 - Oncologia Medica | |
| Data di pubblicazione: | 1993 | |
| Rivista: | ||
| Tipologia: | Article (author) | |
| Digital Object Identifier (DOI): | http://dx.doi.org/10.3109/02841869309083918 | |
| Appare nelle tipologie: | 01 - Articolo su periodico |
File in questo prodotto:
| File | Descrizione | Tipologia | Licenza | |
|---|---|---|---|---|
| Treatment of Carcinoid Syndrome with Recombinant Interferon Alpha 2a.pdf | Publisher's version/PDF | Administrator Richiedi una copia |
Pubblicazioni consigliate
Copyright © 2021